These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16782211)

  • 41. Glucocorticoid antagonism limits adiposity rebound and glucose intolerance in young male rats following the cessation of daily exercise and caloric restriction.
    Teich T; Dunford EC; Porras DP; Pivovarov JA; Beaudry JL; Hunt H; Belanoff JK; Riddell MC
    Am J Physiol Endocrinol Metab; 2016 Jul; 311(1):E56-68. PubMed ID: 27143556
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Attenuated Weight Gain with the Novel Analog of Olanzapine Linked to Sarcosinyl Moiety (PGW5) Compared to Olanzapine.
    Taler M; Vered I; Globus R; Shbiro L; Weizman A; Weller A; Gil-Ad I
    J Mol Neurosci; 2016 Jan; 58(1):66-73. PubMed ID: 26572534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of naltrexone on food intake and body weight gain in olanzapine-treated rats.
    Kurbanov DB; Currie PJ; Simonson DC; Borsook D; Elman I
    J Psychopharmacol; 2012 Sep; 26(9):1244-51. PubMed ID: 22723540
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of famotidine addition on olanzapine-induced weight gain in first-episode schizophrenia patients: a double-blind placebo-controlled pilot study.
    Poyurovsky M; Tal V; Maayan R; Gil-Ad I; Fuchs C; Weizman A
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):332-6. PubMed ID: 15163444
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C.
    Lord CC; Wyler SC; Wan R; Castorena CM; Ahmed N; Mathew D; Lee S; Liu C; Elmquist JK
    J Clin Invest; 2017 Sep; 127(9):3402-3406. PubMed ID: 28805659
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of antipsychotics on the density of cannabinoid receptors in the dorsal vagal complex of rats: implications for olanzapine-induced weight gain.
    Weston-Green K; Huang XF; Han M; Deng C
    Int J Neuropsychopharmacol; 2008 Sep; 11(6):827-35. PubMed ID: 18257959
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lack of Ovarian Secretions Reverts the Anabolic Action of Olanzapine in Female Rats.
    Skrede S; González-García I; Martins L; Berge RK; Nogueiras R; Tena-Sempere M; Mellgren G; Steen VM; López M; Fernø J
    Int J Neuropsychopharmacol; 2017 Dec; 20(12):1005-1012. PubMed ID: 29020342
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Olanzapine depot exposure in male rats: Dose-dependent lipogenic effects without concomitant weight gain.
    Fernø J; Ersland KM; Duus IH; González-García I; Fossan KO; Berge RK; Steen VM; Skrede S
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):923-32. PubMed ID: 25823694
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypothalamic histamine H1 receptor-AMPK signaling time-dependently mediates olanzapine-induced hyperphagia and weight gain in female rats.
    He M; Zhang Q; Deng C; Wang H; Lian J; Huang XF
    Psychoneuroendocrinology; 2014 Apr; 42():153-64. PubMed ID: 24636512
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Olanzapine depot formulation in rat: a step forward in modelling antipsychotic-induced metabolic adverse effects.
    Skrede S; Martins L; Berge RK; Steen VM; López M; Fernø J
    Int J Neuropsychopharmacol; 2014 Jan; 17(1):91-104. PubMed ID: 23919889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of ranitidine in olanzapine-induced weight gain: a dose-response study.
    Mehta VS; Ram D
    Early Interv Psychiatry; 2016 Dec; 10(6):522-527. PubMed ID: 25529756
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Energy metabolism, leptin, and biochemical parameters are altered in rats subjected to the chronic administration of olanzapine.
    Zugno AI; Barcelos M; Oliveira Ld; Canever L; Luca RD; Fraga DB; Matos MP; Rezin GT; Scaini G; Búrigo M; Streck EL; Quevedo J
    Braz J Psychiatry; 2012 Jun; 34(2):168-75. PubMed ID: 22729413
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypothalamic ghrelin signalling mediates olanzapine-induced hyperphagia and weight gain in female rats.
    Zhang Q; He M; Deng C; Wang H; Lian J; Huang XF
    Int J Neuropsychopharmacol; 2014 May; 17(5):807-18. PubMed ID: 24468236
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.
    Kinon BJ; Basson BR; Gilmore JA; Tollefson GD
    J Clin Psychiatry; 2001 Feb; 62(2):92-100. PubMed ID: 11247108
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A role of neuropeptide CART in hyperphagia and weight gain induced by olanzapine treatment in rats.
    Nakhate KT; Subhedar NK; Kokare DM
    Brain Res; 2018 Sep; 1695():45-52. PubMed ID: 29775565
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glucocorticoid antagonist RU38486 fails to block acid-induced muscle wasting in vivo or in vitro.
    Pickering WP; Baker FE; Brown J; Butler HL; Govindji S; Parsons JM; Pawluczyk IZ; Walls J; Bevington A
    Nephrol Dial Transplant; 2003 Aug; 18(8):1475-84. PubMed ID: 12897084
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phosphorylation of hypothalamic AMPK on serine(485/491) related to sustained weight loss by alpha-lipoic acid in mice treated with olanzapine.
    Kim H; Park M; Lee SK; Jeong J; Namkoong K; Cho HS; Park JY; Lee BI; Kim E
    Psychopharmacology (Berl); 2014 Oct; 231(20):4059-69. PubMed ID: 24733236
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
    Saddichha S; Ameen S; Akhtar S
    J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A parametric analysis of olanzapine-induced weight gain in female rats.
    Cooper GD; Pickavance LC; Wilding JP; Halford JC; Goudie AJ
    Psychopharmacology (Berl); 2005 Aug; 181(1):80-9. PubMed ID: 15778884
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Time-dependent effects of olanzapine treatment on the expression of histidine decarboxylase, H1 and H3 receptor in the rat brain: The roles in olanzapine-induced obesity.
    He M; Zhang Q; Deng C; Jin T; Song X; Wang H; Huang XF
    Psychoneuroendocrinology; 2017 Nov; 85():190-199. PubMed ID: 28886461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.